CNMD - Conmed Corp.
(NaN%)
Sell
Moderate Growth but Declining●Stock Price Very High
46%
based on last 5 year data.
Income Statement is MODERATE
Revenue Growth is 13.15%
Operating Income Growth is 97.61%
Net Income Growth is 19976.77%
Earnings Per Share (EPS) turning Positive
Net Margin is 6.29%
Balance Sheet is WEAK
Current Asset to Current Liability Ratio is 2.42
Debt Ratio is 0.57
Current Debt to Net Income Ratio is 0.82
Total Debt to Total Assets Ratio is 0.41
Cash Flow is MODERATE
Cash from Operations Growth is 15.09%
Capital Expenditure is Low
Net Increase in Cash is Negative
Long Term Score Trend is NEGATIVE
Investment Risk is High
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Conmed Corp. (CNMD) - www.conmed.com
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.Exchange - NEW YORK STOCK EXCHANGE INC.
Industry - Surgical and Medical Instrument Manufacturing
Sector - Manufacturing
CEO - Curt Hartman
Employees - 3,400
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.
Know the Stock © 2021 and future.